Scaling Cell and Gene Therapy Logistics
For CGTs to reach their full potential and achieve global accessibility, scalable logistics systems are vital. This article delves into the challenges and innovative solutions shaping the scalability of CGT logistics.
Elevating the Cold Chain Experience Digitally
This whitepaper examines the forces driving digital modeling ecosystems, provides examples of digital modeling successes from other industries, and discusses the pain points in the current pharmaceutical shipping cold chain that digital modeling technology could potentially alleviate.
CGT Cryo M Data Sheet
Reusable Cryogenic Solutions Elevating Cell & Gene Therapy Transport
CGT Ultra D Data Sheet
High-Performing Dry Ice Dewar for Your CGT Shipping Needs
CGT Cryo S Data Sheet
Advanced Single-Use Cryogenic Solutions for Cell & Gene Therapy
CSafe’s Cold Chain Packaging Qualification Services Brochure
Unmatched Cold Chain Confidence with Rigorously Tested, Fully Qualified Shipping Solutions
Elevating Cell and Gene Therapy Logistics: 7 ways CSafe adds value outside the box
This article highlights seven key ways CSafe adds value outside the box across the pharmaceutical product life cycle.
CSafe expands its Cell & Gene Therapy portfolio with launch of high-performing CGT Ultra D
Latest dewar innovations will be showcased at the 2024 Cell & Gene Meeting on the Mesa event in Phoenix, Arizona Monroe, OH – October 3rd: CSafe, a global provider of end-to-end cold chain shipping solutions for the pharmaceutical industry, launches the CGT Ultra D – a multi-use, dry ice dewar built to meet the evolving […]
Rethinking logistics, the key barrier to scaling cell and gene therapies
This article discusses the critical role that logistics play in enabling patients to gain access to cell and gene therapies, and the steps pharma companies must take to scale up breakthrough discoveries to a viable commercial product offering.
CSafe Elevates Cell and Gene Therapy Transport with Reusable Cryogenic Solution
CSafe, an active and passive temperature-controlled shipping solutions provider for the biopharmaceutical industry, proudly announces the launch of a new line of cryogenic multi-use dewars for the cell and gene therapy market. The progressive technology, which is the first in CSafe’s CGT Cryo Series, maintains temperatures colder than -150°C. The reusable dewars and high-impact-resistant shipping […]
